findmyKOL

James Nora, MD

Basic profile

University of Colorado Boulder

ORCIDNone on fileNPI
RegionLincoln, NE · MidwestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1994Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

James Nora is an Infectious Disease physician affiliated with University of Colorado Boulder. OpenAlex indexes 141 publications with 4,629 citations (h-index 37).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
141publications

Distinct works indexed by OpenAlex.

4,629citations

Total citations across indexed works.

37h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 S 48th St
Ste 506
Lincoln, NE 685061225

Telephone

402-489-1110

Registry record last updated 11 Jan 2008.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    66.2%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor16.7%
    Dovato76%Tivicay25%
    Part D<11 patients
    Tetracycline-class Drug13.7%
    Doxycycline Hyclate100%
    Part D12 patients

    + 5 more classes in this area

  • Cardiovascular

    14.7%
    Calcium channel blocker5.1%
    Amlodipine Besylate100%
    Part D<11 patients
    Statin4.8%
    Atorvastatin Calcium100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    8.9%
    Proton pump inhibitor5.1%
    Pantoprazole Sodium100%
    Part D<11 patients
    Vitamin D3 Analog3.8%
    Calcitriol100%
    Part D<11 patients
Where care is delivered (Part B)86% facility · 14% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”